A relative of a veterinary de-worming pill, in combination with the standard treatment Nexavar (sorafenib), was found to halt the growth of hepatocellular cancer (HCC) in laboratory…
A subset of stem cell-derived immune cells, known as iPS-ML, stopped tumor progression and improved survival of mice with liver cancer, a Japanese study showed.
The transforming growth factor-beta (TGF-beta) protein promotes the conversion of normal liver cells to cancerous cells, a study indicates. It also regulates liver cancer cells’ ability to…
A diet too low in protein causes the liver to shrink extensively and become less efficient in doing its work. That can have devastating effects…
CymaBay Therapeutics has named Sujal Shah as interim president and CEO following the retirement of Harold Van Wart, PhD. Robert Wills, PhD, will serve as executive…
Insulin resistance (IR) is associated with poorer cognitive performance and greater cognitive decline in heart disease patients with or without diabetes, a new study says. The…
Dysbiosis, an imbalance in the proportion and activity of bacterial groups of the gut microbiota, can actually aid in liver metabolism and protect the body against…
A healthy diet and regular physical exercise were found to influence the levels of circulating fatty acids, a type of lipid molecules, and reduce the…
A peptide called pNaKtide has shown promise in improving the clinical manifestations associated with non-alcoholic fatty liver disease (NAFLD) and atherosclerosis, according to researchers at Marshall…
The U.S. Food and Drug Administration has granted orphan drug status to cabozantinib for the treatment of hepatocellular carcinoma, the most common type of liver cancer.